Reaction

Cerebral Haematoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,311 reports · 90 co-occurring drugs

As of the last recalculation, Cerebral Haematoma appears in 3,311 FAERS reports alongside 90 co-occurring drug terms. The strongest observed disproportionality signal is ALTEPLASE (PRR 53.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alteplase	124	53.9	54.3
Fondaparinux Sodium	51	40.2	40.5
Heparin Sodium	54	25.1	25.2
Nebivolol	47	18.8	18.9
Dabigatran Etexilate Mesylate	156	14.1	14.1
Rivaroxaban	408	13.9	13.9
Dabigatran Etexilate	161	13.6	13.7
Sotalol Hydrochloride	34	13.0	13.0
Ado-Trastuzumab Emtansine	16	12.0	12.0
Enoxaparin Sodium	106	11.9	12.0
Paroxetine Hydrochloride Hemihydrate	60	11.5	11.5
Candesartan Cilexetil	47	11.4	11.4
Paroxetine	60	11.3	11.3
Norepinephrine	18	10.6	10.7
Micafungin Sodium	14	10.4	10.4
Clopidogrel Bisulfate	156	10.0	10.0
Norepinephrine Bitartrate	22	9.7	9.7
Posaconazole Delayed-Release	16	9.2	9.2
Nebivolol Hydrochloride	48	9.1	9.1
Clopidogrel	259	8.8	8.8
Ganciclovir	14	8.6	8.6
Ganciclovir Sodium	14	8.3	8.4
Sodium Bicarbonate	30	8.2	8.2
Sodium Bicarbonate Injection,	30	8.2	8.2
Amphotericin B	16	8.1	8.1
Oxazepam	27	8.0	8.0
Bisoprolol Fumarate	158	7.6	7.6
Escitslopram	69	7.6	7.6
Apixaban	79	7.6	7.6
Iron Sucrose	11	7.3	7.3
Escitalopram Oxalate	80	7.0	7.0
Amlodipine Besylate And Valsartan	12	6.8	6.8
Dexamethasone Sodium Phosphate	11	6.8	6.8
Posaconazole	16	6.2	6.2
Prasugrel Hydrochloride	10	6.2	6.2
Cefepime	14	6.2	6.2
Phytonadione	8	5.9	5.9
Paroxetine Hydrochloride	80	5.6	5.6
Enalapril Maleate	22	5.6	5.6
Ramipril	107	5.6	5.6
Cefepime Hydrochloride	14	5.5	5.5
Venlafaxine	61	5.4	5.4
Telmisartan	15	5.3	5.3
Esomeprazole	50	5.1	5.1
Brinzolamide	7	5.1	5.1
Amiodarone Hydrochloride	9	5.1	5.1
Erythromycin	15	5.0	5.0
Metolazone	9	5.0	5.0
Rivastigmine	15	5.0	5.0
Sitagliptin And Metformin Hydrochloride	17	5.0	5.0
Ticagrelor	25	5.0	5.0
Indapamide	14	4.9	4.9
Piperacillin Sodium,Tazobactam Sodium	20	4.8	4.8
Warfarin	93	4.7	4.7
Irbesartan	33	4.7	4.7
Linezolid	22	4.7	4.7
Pravastatin Sodium	14	4.5	4.5
Atenolol	92	4.4	4.4
Voriconazole Injection	15	4.4	4.4
Enalapril	37	4.2	4.2
Donepezil Hydrochloride	24	4.1	4.1
Pegaspargase	8	4.1	4.1
Warfarin Sodium	30	4.1	4.1
Fesoterodine Fumarate	7	4.1	4.1
Hydroxyurea	13	3.9	3.9
Dutasteride	5	3.9	3.9
Propofol	22	3.8	3.8
Fam-Trastuzumab Deruxtecan-Nxki	6	3.7	3.7
Meropenem	19	3.7	3.7
Levetiracetam	78	3.7	3.7
Febuxostat Tablets 40 Mg	6	3.7	3.7
Febuxostat Tablets 80 Mg	6	3.7	3.7
Letrozole Tablets	27	3.5	3.6
Sofosbuvir	11	3.5	3.5
Efavirenz	6	3.4	3.4
Ibrutinib	40	3.1	3.1
Insulin Glulisine	5	3.1	3.1
Sunitinib Malate	18	2.9	2.9
Regorafenib	5	2.7	2.7
Vemurafenib	5	2.6	2.6
Levodopa	5	2.6	2.6
Acalabrutinib	5	2.6	2.6
Trastuzumab	28	2.6	2.6
Brimonidine Tartrate	7	2.5	2.5
Inclisiran	3	2.4	2.4
Ethyl Alcohol	10	2.3	2.3
Abemaciclib	7	2.2	2.2
Dabrafenib	7	2.1	2.1
Emicizumab	4	2.0	2.0
Axitinib	6	1.9	1.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.